Interview with Gabor Somlyai, Managing Director, HYD LLC.
You founded HYD almost 20 years ago, in 1992. Can you first explain to our readers why you made the switch from doing research at the Hungarian Institute of Oncology…
Your chemistry partner for research & development
SONEAS Research is a professional chemical service provider with a pragmatic approach to innovation, enabling us to create opportunities and add value to our clients’ projects. Established in 1996 and having our pilot plant facility commissioned in 2002 we now provide a comprehensive range of chemistry services to support pharmaceutical and fine chemicals development.
Operating from two sites in Budapest – research, analytical laboratories, and an 8,000 m2 facility housing our process R&D labs, kilo lab and pilot plant – we have the skills, knowledge and experience to deliver your materials when you need them.
SONEAS Chemicals is a CMO company operating on 65,000 m2 and capable to provide starting materials, intermediates pharma and non-pharma applications as well as other fine chemical products on commercial scale.
Contact
Illatos út 33.
H-1097 Budapest
Hungary
Tel: +36 1 347 5060
Fax: +36 1 347 5061
Email: info@soneas.com
You founded HYD almost 20 years ago, in 1992. Can you first explain to our readers why you made the switch from doing research at the Hungarian Institute of Oncology…
Hungary has been recognized as one of the largest pharmaceutical and healthcare markets in Central and Eastern Europe, and can obviously not be ignored by Roche. First of all, can…
You took over as GM back in 2008. No doubt that this was a challenging time to run a business, in particular in view of the external economic environment. Can…
The Hungarian pharmaceutical environment has been undergoing a turbulent time recently, with many new measures being implement by the Government. What are your observations, and how do you expect companies…
Assign Group started in 2002 as a small local CRO company founded in Austria; monitoring and doing minor project management only. Why was Austria chosen as the headquarters? First, it…
With approximately $90 billion flowing into the country (according to the Hungarian Investment and Trade Agency) since it abolished its centrally planned economy and transformed into an open, pro-business economy…
Taking a look at the voices of the pharmaceutical industry in Hungary, we see AIPM and MAYGOSZ as the 2 key associations. And while MAGYOSZ already represents many generic players……
IMS is a strong brand name when it comes to pharma and healthcare information worldwide. Can you please elaborate on the particularities that set the Hungarian pharmaceutical market apart from…
The Hungarian pharmaceutical environment has been undergoing many changes recently, such as a sales tax increase to 20%. Do you feel this is a climate of threat to MNCs in…
Looking at Boehringer Ingelheim (BI) in Hungary, at first glance we see a company with a presence of already 20 years, which basically means an entry into this market right…
Sanofi for 3,5 years. It must have been quite a different market, culture and environment. Yet, at that time you publicly announced that it only took you 30 seconds to…
Hungary has one of the oldest drug industries in Europe, but homeopathy too has quite a history in the country, with the Homoeopathic Doctor’s Association being founded as early as…
See our Cookie Privacy Policy Here
